Register for streaming realtime charts, analysis tools, and prices.
Period:
Draw Mode:
| Volume | 10,598 |
|
|||||
| News | - | ||||||
| Day High | 7.1845 | Low High |
|||||
| Day Low | 7.03 | ||||||
| Company Name | Stock Ticker Symbol | Market | Type |
|---|---|---|---|
| Aura Biosciences Inc | AURA | NASDAQ | Common Stock |
| Price Change | Change Percent | Stock Price | Last Traded
|
|
|---|---|---|---|---|
| 0.1245 | 1.76% | 7.1845 | 10:07:25 |
| Open Price | Low Price | High Price | Close Price | Prev Close |
|---|---|---|---|---|
| 7.03 | 7.03 | 7.1845 | 7.06 |
| Trades | Volume | VWAP | Dollar Volume | Avg Volume | 52 Week Range |
|---|---|---|---|---|---|
| 127 | 10,598 | $ 7.04 | $ 74,595 | - | 5.99 - 13.50 |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| 10:07:25 | 700 | $ 7.1845 | USD |
Aura Biosciences Inc Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| 272.41M | 38.26M | - | 0 | -76.41M | -2.00 | - |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | - | - | - |
Aura Biosciences News
Loading Messages....
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical AURA Price Data
| Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 7.62 | 7.71 | 6.95 | 7.24 | 113,037 | -0.4355 | -5.72% |
| 1 Month | 8.55 | 8.74 | 6.95 | 7.57 | 130,493 | -1.37 | -15.97% |
| 3 Months | 7.63 | 9.72 | 6.95 | 7.87 | 187,478 | -0.4455 | -5.84% |
| 6 Months | 8.46 | 12.35 | 5.99 | 8.03 | 205,224 | -1.28 | -15.08% |
| 1 Year | 8.71 | 13.50 | 5.99 | 8.76 | 137,349 | -1.53 | -17.51% |
| 3 Years | 14.10 | 26.16 | 5.99 | 11.51 | 111,624 | -6.92 | -49.05% |
| 5 Years | 14.10 | 26.16 | 5.99 | 11.51 | 111,624 | -6.92 | -49.05% |
Aura Biosciences Description
| Aura Biosciences Inc is a clinical-stage oncology company developing a novel technology platform based on virus-like drug conjugates to target and destroy cancer cells selectively while activating the immune system to create long-lasting anti-tumor immunity. |
